View this email in your browser
Share Share
Tweet Tweet
Forward Forward

for Health and Social Care

Bringing you our latest news, features and guidance.
April 2022
COVID-19NewsSocial care | Get involved | Blogs | Other resources
Welcome to your new NICE News for Health and Social Care newsletter. This updated format incorporates all your usual NICE updates, along with social care news from across the organisation. It also highlights topics that extend across the health, social care and public health interface.


Updates to managing COVID-19 guideline

We have updated our existing recommendations on:

We have added new recommendations on:
We are continuously updating our COVID-19 guidelines to incorporate the latest evidence and keep abreast of new developments in diagnosing and treating COVID-19. We’ll highlight recent updates in this monthly email communication, or you can keep up to date on the latest live changes through our website.


Person doing a diabetes glucose test

Real-time monitoring to benefit thousands of people with diabetes

We’ve published updated guidance on type 1 diabetes in adults and type 1 and type 2 diabetes in children and young people. More than 250,000 people are set to benefit from new technology to help them manage their type 1 diabetes and reduce the need for finger-prick testing by up to 50%. Our guidance recommends the use of real-time continuous glucose monitoring and expands the use of intermittently scanned glucose monitoring devices – also known as flash monitoring – to the whole of the type 1 patient population.

X-ray film of replaced knee

Quality standard on joint replacement

We’ve published a quality standard on primary elective hip, knee or shoulder joint replacement. It covers the care of adults before, during and after surgery. The standard sets out advice on pre and postoperative rehabilitation, the use of tranexamic acid during surgery to minimise blood loss, the prevention of implant selection errors, and giving adults a choice on partial or total replacement.

First new treatment for osteoporosis for over a decade

Our final draft guidance recommends romosozumab as a new treatment for people with severe osteoporosis who are at high risk of fractures after the menopause. Clinical trial evidence showed that romosozumab followed by alendronic acid is more effective at reducing the risk of fractures than alendronic acid alone. Over 20,000 people could be eligible for the new treatment.

Keep the size of your waist to less than half of your height

Our new draft guideline on obesity recommends people should keep their waist measurement to less than half their height. Adults with a body mass index (BMI) below 35 kg/m² (obesity class 2) are encouraged to measure their own waist-to-height ratio. Using the waist-to-height ratio, in conjunction with the BMI, can provide an estimate of the accumulation of fat around the abdomen to help assess health risks, such as type 2 diabetes, hypertension or cardiovascular disease. A consultation on the proposed recommendations is open until Wednesday 11 May 2022.

Tackling antimicrobial resistance through subscription-style payment model

Two new antimicrobial drugs - cefiderocol and ceftazidime–avibactam - could, in the next few months, be the first to be made available as part of a new innovative subscription-style payment model. The drugs will be used to treat patients with severe drug-resistant infections who would otherwise have limited or no other treatment options. The new model has been designed to try and address the lack of new antimicrobials being developed and the growing threat posed by antimicrobial resistance.

Catch up on our latest news

Interview with our chief executive, Dr Sam Roberts

In this month’s NICE Talks podcast, we chat with chief executive, Dr Sam Roberts. Sam outlines her initial thoughts on the organisation, her priorities for the next 12 months and how she plans to tackle some of the challenges we face. She reflects on how NICE will adapt to new drugs, digital technologies, devices and diagnostics and explains how she’ll build upon the solid foundations established by her predecessors.

Social care

Quick guide to supporting carers

We’ve published a new quick guide on supporting people who provide unpaid care for adults with health or social care needs. Aimed at social care practitioners, it includes information on:

  • assessing carers’ needs
  • carers’ breaks
  • peer support
  • work, education and training
  • psychological and emotional support.
The quick guide is based on our supporting adult carers guideline. We’ve also published a quality standard on this topic and delivered a webinar in partnership with the Social Care Institute for Excellence.
Read quick guide

Get involved

Help shape the future of NICE guidelines

We want to change the way NICE guidance appears online to make it more useful and usable.
We’ve created an early prototype for how our Type 2 diabetes in adults: management guideline could look in the future, and we’d like to know what you think of it.
Redesigning our guidance will help you find up-to-date information you need when you need it, in the right format. It will be easier to navigate, more accessible and enable you to access the underpinning evidence to support shared decision making.

View the prototype

Share your feedback on real world evidence (RWE) framework

We are inviting feedback on our draft RWE framework. The framework describes best practices for planning, conducting and reporting real world evidence studies, including the assessment of data suitability. We’ve designed it to help life science companies and other stakeholders when developing their evidence generation plans and our committees when evaluating such evidence.

Share your views before Friday 29 April 2022.

Comment on framework

Following your feedback and any changes we may make as a result, we plan to launch the RWE framework in June 2022. We are holding a launch event:

  • Thursday 23 June 2022, 2pm to 3pm, online.

We’ve designed the event for a wide audience including healthcare professionals, patient groups, academics, pharmaceutical companies and medical technology developers. You will find out how the RWE framework could help you resolve knowledge gaps and drive forward patient access to innovative treatments by:

  • identifying where real world data can be used to reduce uncertainties and improve guidance
  • describing best practices for the planning, conduct, and reporting of real-world evidence studies to improve the quality and transparency of evidence.
Register for your free ticket

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
See all our open consultations

Join a committee

We have a number of vacancies for health and care professionals and lay people to join our committees. Topics include mental wellbeing in over 65s, falls in older people and sepsis. Join us and have an active role in producing a guideline or quality standard.

See all our committee vacancies

Observe a meeting

We’re currently holding all our public meetings virtually. You'll need to register in advance to join. 

Upcoming public meeting:

  • Friday 20 May 2022 – Medical technology advisory committee
    Registration closes on Friday 13 May 2022.
    Agenda and register
Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent.
See all our public meetings


Harriet Unsworth is technical adviser for digital health at NICE

Shape our evidence standards framework

Harriet Unsworth is technical adviser for digital health at NICE. In her recent blog post, she outlines her role in updating our evidence standards framework for digital and artificial intelligence health technologies. She also explains how you can share your views as part of our consultation.

Read more of our latest blog posts

Other resources

Lancet interview with our chief executive

In a recent interview, our chief executive, Dr Sam Roberts, discusses how her work at NICE is informed by her clinical experience and her belief that the patient is the expert.

Read Lancet interview

unsubscribe from this list